help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruan, W.
Right arrow Articles by Kleinberg, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruan, W.
Right arrow Articles by Kleinberg, D. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL

Endocrinology, Vol 136, 1296-1302, Copyright © 1995 by Endocrine Society

ARTICLES

Estradiol enhances the stimulatory effect of insulin-like growth factor- I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid

W Ruan, V Catanese, R Wieczorek, M Feldman and DL Kleinberg
Department of Medicine, Department of Veterans Affairs Medical Center, New York, New York.

Pubertal mammary development in the rat is largely dependent upon GH and estrogen. We recently showed that insulin-like growth factor-I (IGF- I) can substitute for GH in inducing mammary development in male rats, suggesting that IGF-I mediates GH action. The present study investigated whether IGF-I, like GH, required estradiol (E2) to act or whether IGF-I could substitute for both GH and E2. The effects of IGF-I were tested in the presence and absence of E2. Elvax pellets containing IGF-I or des(1-3) IGF-I were implanted into right lumbar mammary glands of sexually immature, hypophysectomized, oophorectomized female rats, with control BSA-containing pellets in the contralateral glands. After 5 days, both lumbar mammary glands were removed and examined in whole mounts for mammary development by counting terminal end buds and alveolar structures. E2, administered in SILASTIC brand capsules, had no independent effect on mammary development. In the absence of E2, des(1-3) IGF-I had a small, but significant, independent effect on mammary development; native IGF-I was ineffective. The addition of E2 significantly enhanced the effects of IGF-I and des(1-3) IGF-I on mammary development, similar to that noted when E2 was given along with GH. We also studied the effects of E2 and/or hGH on mammary gland IGF-I messenger RNA (mRNA) in hypophysectomized castrated male animals. E2 alone did not increase mammary gland IGF-I mRNA concentrations, but E2 enhanced the effect of hGH on IGF-I mRNA by 4- to 6-fold. These studies indicate that IGF-I can have a small independent effect on mammary development, but like GH, E2 is required for a full effect. They also indicate that E2 is capable of synergizing with GH in the production or expression of IGF-I mRNA, and that the action of E2 on mammary development may take place at multiple sites. If locally produced IGF-I does indeed mediate the action of GH in mammary development, then although E2 is capable of enhancing the effect of GH on IGF-I mRNA, its major effect in mammary development occurs after IGF-I is produced.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
D. L. Kleinberg, T. L. Wood, P. A. Furth, and A. V. Lee
Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions
Endocr. Rev., February 1, 2009; 30(1): 51 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
W. Wen, X. O. Shu, H. Li, G. Yang, B.-T. Ji, H. Cai, Y.-T. Gao, and W. Zheng
Dietary carbohydrates, fiber, and breast cancer risk in Chinese women
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 283 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Baglietto, D. R. English, J. L. Hopper, H. A. Morris, W. D. Tilley, and G. G. Giles
Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 763 - 768.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. N. Lucas, D. G. Rudmann, K. M. Credille, A. R. Irizarry, A. Peter, and P. W. Snyder
The Rat Mammary Gland: Morphologic Changes as an Indicator of Systemic Hormonal Perturbations Induced by Xenobiotics
Toxicol Pathol, February 1, 2007; 35(2): 199 - 207.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. Ruan, F. Fahlbusch, D. R. Clemmons, M. E. Monaco, P. D. Walden, A. P. Silva, H. A. Schmid, and D. L. Kleinberg
SOM230 Inhibits Insulin-Like Growth Factor-I Action in Mammary Gland Development by Pituitary Independent Mechanism: Mediated through Somatostatin Subtype Receptor 3?
Mol. Endocrinol., February 1, 2006; 20(2): 426 - 436.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. Ruan, M. E. Monaco, and D. L. Kleinberg
Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action
Endocrinology, March 1, 2005; 146(3): 1170 - 1178.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
E. G. Brown, M. J. VandeHaar, K. M. Daniels, J. S. Liesman, L. T. Chapin, J. W. Forrest, R. M. Akers, R. E. Pearson, and M. S. W. Nielsen
Effect of Increasing Energy and Protein Intake on Mammary Development in Heifer Calves
J Dairy Sci, February 1, 2005; 88(2): 595 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Yu, X.-O. Shu, B. D. L. Li, Q. Dai, Y.-T. Gao, F. Jin, and W. Zheng
Joint Effect of Insulin-like Growth Factors and Sex Steroids on Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1067 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. J. Allan, E. Tonner, M. C. Barber, M. T. Travers, J. H. Shand, R. G. Vernon, P. A. Kelly, N. Binart, and D. J. Flint
Growth Hormone, Acting in Part through the Insulin-Like Growth Factor Axis, Rescues Developmental, But Not Metabolic, Activity in the Mammary Gland of Mice Expressing a Single Allele of the Prolactin Receptor
Endocrinology, November 1, 2002; 143(11): 4310 - 4319.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Oesterreich, P. Zhang, R. L. Guler, X. Sun, E. M. Curran, W. V. Welshons, C. K. Osborne, and A. V. Lee
Re-expression of Estrogen Receptor {alpha} in Estrogen Receptor {alpha}-negative MCF-7 Cells Restores both Estrogen and Insulin-like Growth Factor-mediated Signaling and Growth
Cancer Res., August 1, 2001; 61(15): 5771 - 5777.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. W. Chan, M. Pollak, and H. Huynh
Inhibition of Insulin-like Growth Factor Signaling Pathways in Mammary Gland by Pure Antiestrogen ICI 182,780
Clin. Cancer Res., August 1, 2001; 7(8): 2545 - 2554.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Gebre-Medhin, L.-G. Kindblom, H. Wennbo, J. Tornell, and J. M. Meis-Kindblom
Growth Hormone Receptor Is Expressed in Human Breast Cancer
Am. J. Pathol., April 1, 2001; 158(4): 1217 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. S. Cohick, B. Wang, P. Verma, and Y. R. Boisclair
Insulin-Like Growth Factor I (IGF-I) and Cyclic Adenosine 3',5'-Monophosphate Regulate IGF-Binding Protein-3 Gene Expression by Transcriptional and Posttranscriptional Mechanisms in Mammary Epithelial Cells
Endocrinology, December 1, 2000; 141(12): 4583 - 4591.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
H. Yu and T. Rohan
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
L Hebbard, A Steffen, V Zawadzki, C Fieber, N Howells, J Moll, H Ponta, M Hofmann, and J Sleeman
CD44 expression and regulation during mammary gland development and function
J. Cell Sci., January 7, 2000; 113(14): 2619 - 2630.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
W. Ruan and D. L. Kleinberg
Insulin-Like Growth Factor I Is Essential for Terminal End Bud Formation and Ductal Morphogenesis during Mammary Development
Endocrinology, November 1, 1999; 140(11): 5075 - 5081.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
A. V. Lee, J. G. Jackson, J. L. Gooch, S. G. Hilsenbeck, E. Coronado-Heinsohn, C. K. Osborne, and D. Yee
Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo
Mol. Endocrinol., May 1, 1999; 13(5): 787 - 796.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
W. Ruan, L. Powell-Braxton, J. J. Kopchick, and D. L. Kleinberg
Evidence That Insulin-Like Growth Factor I and Growth Hormone Are Required for Prostate Gland Development
Endocrinology, May 1, 1999; 140(5): 1984 - 1989.
[Abstract] [Full Text]

Home page
 JCBHome page
N. Farrelly, Y.-J. Lee, J. Oliver, C. Dive, and C. H. Streuli
Extracellular Matrix Regulates Apoptosis in Mammary Epithelium through a Control on Insulin Signaling
J. Cell Biol., March 22, 1999; 144(6): 1337 - 1348.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. M. Richert and T. L. Wood
The Insulin-Like Growth Factors (IGF) and IGF Type I Receptor during Postnatal Growth of the Murine Mammary Gland: Sites of Messenger Ribonucleic Acid Expression and Potential Functions
Endocrinology, January 1, 1999; 140(1): 454 - 461.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
P. D. Walden, W. Ruan, M. Feldman, and D. L. Kleinberg
Evidence That the Mammary Fat Pad Mediates the Action of Growth Hormone in Mammary Gland Development
Endocrinology, February 1, 1998; 139(2): 659 - 662.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. B. Silberstein, K. Van Horn, P. Strickland, C. T. Roberts Jr., and C. W. Daniel
Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
PNAS, July 22, 1997; 94(15): 8132 - 8137.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. Clark
The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function
Endocr. Rev., April 1, 1997; 18(2): 157 - 179.
[Abstract] [Full Text]

Home page
 Reproductive SciencesHome page
F. I. Sharara and L. C. Giudice
Role of Gorwth Hormone in Ovarian Physiology and Onest of Puberty
Reproductive Sciences, January 1, 1997; 4(1): 2 - 7.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
J. Dupont, M. Karas, and D. LeRoith
The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components
J. Biol. Chem., November 10, 2000; 275(46): 35893 - 35901.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society